Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Rubio

Showing results (241-250 of 268) with videos related to

Pageof 27
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 18, 2021
Predicting critical illness on initial diagnosis of COVID-19 based on easily obtained clinical variables: development and validation of the PRIORITY modelMiguel Martínez-Lacalzada, Adrián Viteri-Noël, Luis Manzano, et al.
The Lancet. Rheumatology|January 24, 2024
The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statementsAnna-Maria Hoffmann-Vold, Toby M Maher, Edward E Philpot, et al.
Journal of Clinical Medicine|June 2, 2021
Risk Categories in COVID-19 Based on Degrees of Inflammation: Data on More Than 17,000 Patients from the Spanish SEMI-COVID-19 RegistryManuel Rubio-Rivas, Xavier Corbella, Francesc Formiga, et al.
Internal and Emergency Medicine|March 2, 2022
Clusters of inflammation in COVID-19: descriptive analysis and prognosis on more than 15,000 patients from the Spanish SEMI-COVID-19 RegistryManuel Rubio-Rivas, José María Mora-Luján, Francesc Formiga, et al.
Canadian Journal of Respiratory Therapy : CJRT = Revue Canadienne De La Therapie Respiratoire : RCTR|June 10, 2024
Assessing the impact of long-term inhaled corticosteroid therapy on patients with COVID-19 and coexisting chronic lung disease: A multicenter retrospective cohort studyAdela Pina Belmonte, Manuel Madrazo, Laura Piles, et al.
Viruses|March 28, 2024
Prognostic Value of D-dimer to Lymphocyte Ratio (DLR) in Hospitalized Coronavirus Disease 2019 (COVID-19) Patients: A Validation Study in a National CohortCrhistian-Mario Oblitas, Pablo Demelo-Rodríguez, Luis-Antonio Alvarez-Sala-Walther, et al.
Journal of Clinical Medicine|November 3, 2020
Predicting Clinical Outcome with Phenotypic Clusters in COVID-19 Pneumonia: An Analysis of 12,066 Hospitalized Patients from the Spanish Registry SEMI-COVID-19Manuel Rubio-Rivas, Xavier Corbella, José María Mora-Luján, et al.
Plos One|May 11, 2021
Inappropriate antibiotic use in the COVID-19 era: Factors associated with inappropriate prescribing and secondary complications. Analysis of the registry SEMI-COVIDJorge Calderón-Parra, Antonio Muiño-Miguez, Alejandro D Bendala-Estrada, et al.
Clinical and Experimental Rheumatology|January 24, 2020
Serodiscordant patients with systemic sclerosis: when antibody does not correspond to skin involvementNerea Iniesta Arandia, Gerard Espinosa, Carles Tolosa Vilella, et al.
Current Medical Research and Opinion|January 17, 2022
The importance of association of comorbidities on COVID-19 outcomes: a machine learning approachJosé Carlos Arévalo-Lorido, Juana Carretero-Gómez, Jose Manuel Casas-Rojo, et al.
Pageof 27

Showing results (241-250 of 268) with videos related to

Sort By:
Pageof 27
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 18, 2021
Predicting critical illness on initial diagnosis of COVID-19 based on easily obtained clinical variables: development and validation of the PRIORITY modelMiguel Martínez-Lacalzada, Adrián Viteri-Noël, Luis Manzano, et al.
The Lancet. Rheumatology|January 24, 2024
The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statementsAnna-Maria Hoffmann-Vold, Toby M Maher, Edward E Philpot, et al.
Journal of Clinical Medicine|June 2, 2021
Risk Categories in COVID-19 Based on Degrees of Inflammation: Data on More Than 17,000 Patients from the Spanish SEMI-COVID-19 RegistryManuel Rubio-Rivas, Xavier Corbella, Francesc Formiga, et al.
Internal and Emergency Medicine|March 2, 2022
Clusters of inflammation in COVID-19: descriptive analysis and prognosis on more than 15,000 patients from the Spanish SEMI-COVID-19 RegistryManuel Rubio-Rivas, José María Mora-Luján, Francesc Formiga, et al.
Canadian Journal of Respiratory Therapy : CJRT = Revue Canadienne De La Therapie Respiratoire : RCTR|June 10, 2024
Assessing the impact of long-term inhaled corticosteroid therapy on patients with COVID-19 and coexisting chronic lung disease: A multicenter retrospective cohort studyAdela Pina Belmonte, Manuel Madrazo, Laura Piles, et al.
Viruses|March 28, 2024
Prognostic Value of D-dimer to Lymphocyte Ratio (DLR) in Hospitalized Coronavirus Disease 2019 (COVID-19) Patients: A Validation Study in a National CohortCrhistian-Mario Oblitas, Pablo Demelo-Rodríguez, Luis-Antonio Alvarez-Sala-Walther, et al.
Journal of Clinical Medicine|November 3, 2020
Predicting Clinical Outcome with Phenotypic Clusters in COVID-19 Pneumonia: An Analysis of 12,066 Hospitalized Patients from the Spanish Registry SEMI-COVID-19Manuel Rubio-Rivas, Xavier Corbella, José María Mora-Luján, et al.
Plos One|May 11, 2021
Inappropriate antibiotic use in the COVID-19 era: Factors associated with inappropriate prescribing and secondary complications. Analysis of the registry SEMI-COVIDJorge Calderón-Parra, Antonio Muiño-Miguez, Alejandro D Bendala-Estrada, et al.
Clinical and Experimental Rheumatology|January 24, 2020
Serodiscordant patients with systemic sclerosis: when antibody does not correspond to skin involvementNerea Iniesta Arandia, Gerard Espinosa, Carles Tolosa Vilella, et al.
Current Medical Research and Opinion|January 17, 2022
The importance of association of comorbidities on COVID-19 outcomes: a machine learning approachJosé Carlos Arévalo-Lorido, Juana Carretero-Gómez, Jose Manuel Casas-Rojo, et al.
Pageof 27